Is USANA Health Sciences (USNA) Stock Undervalued Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
USNA or UTHR: Which Is the Better Value Stock Right Now?
Investors interested in Medical - Drugs stocks are likely familiar with USANA Health Sciences (USNA) and United Therapeutics (UTHR). But which of these two stocks is more attractive to value investors?
USANA Health Sciences, Inc. (USNA) Q4 2025 Earnings Call Transcript
USANA Health Sciences, Inc. (USNA) Q4 2025 Earnings Call Transcript
USANA Health Sciences (USNA) Q4 Earnings and Revenues Beat Estimates
USANA Health Sciences (USNA) came out with quarterly earnings of $0.6 per share, beating the Zacks Consensus Estimate of $0.41 per share. This compares to earnings of $0.64 per share a year ago.
Analysts Estimate USANA Health Sciences (USNA) to Report a Decline in Earnings: What to Look Out for
USANA Health (USNA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
USANA Q3 2025 Preview: Short-Term Challenges Amid Strategic Transition
USANA Health Sciences faces short-term pain as Q3 preliminary results reveal declining profitability despite modest sales growth and ongoing business transition. USNA's new Brand Partner compensation plan and Hiya acquisition are causing temporary disruptions, but management expects double-digit Hiya growth and operational improvements by 2026. Valuation remains attractive, with USNA trading at significant discounts to sector averages, supported by a strong balance sheet and no debt.
USNA vs. STVN: Which Stock Is the Better Value Option?
Investors with an interest in Medical - Drugs stocks have likely encountered both USANA Health Sciences (USNA) and Stevanato Group (STVN). But which of these two stocks is more attractive to value investors?
Is USANA Health Sciences (USNA) a Great Value Stock Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Should Value Investors Buy USANA Health Sciences (USNA) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
USNA vs. STVN: Which Stock Is the Better Value Option?
Investors looking for stocks in the Medical - Drugs sector might want to consider either USANA Health Sciences (USNA) or Stevanato Group (STVN). But which of these two stocks presents investors with the better value opportunity right now?
Are Investors Undervaluing USANA Health Sciences (USNA) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
USANA Health (USNA) Upgraded to Buy: Here's Why
USANA Health (USNA) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
